Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
MC LC 1
Many researchers have focused on understanding the mode of action of inhibitors that can act differently depending on the DGF-in or DFG-out conformation
1 Introduction Metabolic dysfunctionassociated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease (NAFLD)) is a dynamic chronic non-communicable liver disease, which displays hepatic steatosis with one or more cardiometabolic risk factors in the absence of other causes of hepatic steatosis, such as drug-induced or alcohol-related steatosis (Sarkar and Kushner, 2025)
References 1 Nature Medicine (2014)Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity (preclinical)
